Trevi Therapeutics, Inc. is a company that provides Clinical trial, Nalbuphine, Counterirritant and more. Trevi Therapeutics, Inc. is headquartered in United States Connecticut. Trevi Therapeutics, Inc. was founded in 2011. Trevi Therapeutics, Inc. has a total of 131 patents and 1 literature
visualizing technology portfolio of hot application areas and blank areas for Trevi Therapeutics, Inc.
Time Range:
Overall
Overall
1 year
3 year
5 year
Application Domain L2
Application Domain L2
Application Domain L3
Application Domain L4
High-Tech Industry L1
High-Tech Industry L2
Tech Topic L2
Tech Topic L3
Timeline
Tech Topic L2
Tech Topic L2
Tech Topic L3
High-Tech Industry L1
High-Tech Industry L2
Application Domain L2
Application Domain L3
Application Domain L4
Download
Subsidiary Lists
Subsidiaries with patent applications for Trevi Therapeutics, Inc.
Sign up to view the full data
Free Trial Now
Download
Trevi Therapeutics, Inc. Frequently Asked Questions
What technical fields has Trevi Therapeutics, Inc. researched?
Trevi Therapeutics, Inc. has researched the technical fields related toClinical trialNalbuphineCounterirritantPatiromerChronic pruritusUremic pruritusPrurigo nodularisLevodopa-induced dyskinesiaOpioid receptorDyskinesiaPeripheral nervous systemPathophysiologyIdiopathic pulmonary fibrosisBiopharmaceuticalDrug
What is Trevi Therapeutics, Inc.'s total number of patents?
Trevi Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically...
What is Trevi Therapeutics, Inc.'s official website?